Clinical trialNCT02781883RecruitingPhase 2Interventional

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

SponsorBio-Path Holdings, Inc.Enrollment108Acute Myeloid Leukemia (AML)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Maro Ohanian, DO
M.D. Anderson Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Ucla Medical Center
Los Angeles, California, United States
Gary Schiller, MD
Recruiting
Georgia Cancer Center at Augusta University
Augusta, Georgia, United States
Vamsi Kota, MD
Recruiting
University of Kansas Cancer Center
Fairway, Kansas, United States
Tara Lin, MD
Recruiting
New Jersey Hematology Oncology Associates
Brick, New Jersey, United States
Terminated
Laura & Isaac Pe Lmutter Cancer Center at Nyu Langone Health
New York, New York, United States
Mohammad Maher Abdul Hay, MD
Recruiting
Weill Cornell Medical College - New York - Presbyterian Hospital
New York, New York, United States
Gail J Roboz, MD
Recruiting
University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Maro Ohanian, MD
Recruiting
Baylor Scott & White Research Institute
Temple, Texas, United States
Terminated
West Virginia University/mary Babb Randolph Cancer Center
Morgantown, West Virginia, United States
Terminated

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2016
Primary completion: 31 Dec 2027
Completion: 31 Dec 2028
Last update posted: 7 Mar 2025
Registered enrollment: 108
Registry id: NCT02781883

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.